+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Tissue Scaffolds Market 2021-2025

  • PDF Icon

    Report

  • 120 Pages
  • March 2021
  • Region: Global
  • TechNavio
  • ID: 5308197
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Tissue Scaffolds Market 2021-2025

The publisher has been monitoring the tissue scaffolds market and it is poised to grow by $ 1.20 bn during 2021-2025 progressing at a CAGR of 11% during the forecast period. The report on tissue scaffolds market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing initiatives and support from public and private healthcare organizations and increasing prevalence of chronic and acute wounds. In addition, increasing initiatives and support from public and private healthcare organizations is anticipated to boost the growth of the market as well.

The tissue scaffolds market analysis includes product segment, application segment and geographical landscapes.

The tissue scaffolds market is segmented as below:

By Product
  • Natural Tissue Scaffolds
  • Synthetic Tissue Scaffolds

By Geographical Landscapes
  • North America
  • Europe
  • Asia
  • ROW

By Application
  • Musculoskeletal
  • Dermatological
  • Cardiovascular
  • Other Applications

This study identifies the increasing adoption of tissue scaffolds as one of the prime reasons driving the tissue scaffolds market growth during the next few years.

The report on tissue scaffolds market covers the following areas:
  • Tissue scaffolds market sizing
  • Tissue scaffolds market forecast
  • Tissue scaffolds market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading tissue scaffolds market vendors that include Integra LifeSciences Holdings Corp., Medtronic Plc, Merck KGaA, MiMedx Group Inc., Nuvasive Inc., Organogenesis Inc., RTI Surgical Holdings Inc., Smith & Nephew plc, Stryker Corp., and Thermo Fisher Scientific Inc.. Also, the tissue scaffolds market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary
  • Market Overview

Market Landscape
  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • Natural tissue scaffolds - Market size and forecast 2020-2025
  • Synthetic tissue scaffolds - Market size and forecast 2020-2025
  • Market opportunity by Product

Customer landscape
Market Segmentation by Application
  • Musculoskeletal
  • Dermatological
  • Cardiovascular
  • Other applications

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape
  • Vendor landscape
  • Landscape disruption
  • Competitive scenario

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Integra LifeSciences Holdings Corp.
  • Medtronic Plc
  • Merck KGaA
  • MiMedx Group Inc.
  • Nuvasive Inc.
  • Organogenesis Inc.
  • RTI Surgical Holdings Inc.
  • Smith & Nephew plc
  • Stryker Corp.
  • Thermo Fisher Scientific Inc.

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Product - Market share 2020-2025 (%)
  • Comparison by Product
  • Natural tissue scaffolds - Market size and forecast 2020-2025 ($ million)
  • Natural tissue scaffolds - Year-over-year growth 2020-2025 (%)
  • Synthetic tissue scaffolds - Market size and forecast 2020-2025 ($ million)
  • Synthetic tissue scaffolds - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Product
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Integra LifeSciences Holdings Corp. - Overview
  • Integra LifeSciences Holdings Corp. - Business segments
  • Integra LifeSciences Holdings Corp. - Key offerings
  • Integra LifeSciences Holdings Corp. - Key customers
  • Integra LifeSciences Holdings Corp. - Segment focus
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Key customers
  • Medtronic Plc - Segment focus
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key offerings
  • Merck KGaA - Key customers
  • Merck KGaA - Segment focus
  • MiMedx Group Inc. - Overview
  • MiMedx Group Inc. - Business segments
  • MiMedx Group Inc. - Key offerings
  • MiMedx Group Inc. - Key customers
  • MiMedx Group Inc. - Segment focus
  • Nuvasive Inc. - Overview
  • Nuvasive Inc. - Product and service
  • Nuvasive Inc. - Key offerings
  • Nuvasive Inc. - Key customers
  • Nuvasive Inc. - Segment focus
  • Organogenesis Inc. - Overview
  • Organogenesis Inc. - Business segments
  • Organogenesis Inc. - Key offerings
  • Organogenesis Inc. - Key customers
  • Organogenesis Inc. - Segment focus
  • RTI Surgical Holdings Inc. - Overview
  • RTI Surgical Holdings Inc. - Business segments
  • RTI Surgical Holdings Inc. - Key offerings
  • RTI Surgical Holdings Inc. - Key customers
  • RTI Surgical Holdings Inc. - Segment focus
  • Smith & Nephew plc - Overview
  • Smith & Nephew plc - Business segments
  • Smith & Nephew plc - Key offerings
  • Smith & Nephew plc - Key customers
  • Smith & Nephew plc - Segment focus
  • Stryker Corp. - Overview
  • Stryker Corp. - Business segments
  • Stryker Corp. - Key offerings
  • Stryker Corp. - Key customers
  • Stryker Corp. - Segment focus
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Key customers
  • Thermo Fisher Scientific Inc. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global tissue scaffolds market: Bioventus LLC, Integra LifeSciences Holdings Corp., Medtronic Plc, Merck KGaA, MiMedx Group Inc., NuVasive Inc., Organogenesis Holdings Inc., RTI Surgical Inc., Smith & Nephew Plc, and Thermo Fisher Scientific Inc.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increasing adoption of tissue scaffolds .'

According to the report, one of the major drivers for this market is the increasing initiatives and support from public and private healthcare organizations.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Integra LifeSciences Holdings Corp.
  • Medtronic Plc
  • Merck KGaA
  • MiMedx Group Inc.
  • Nuvasive Inc.
  • Organogenesis Inc.
  • RTI Surgical Holdings Inc.
  • Smith & Nephew plc
  • Stryker Corp.
  • Thermo Fisher Scientific Inc.